A phase IV, single group study to evaluate the immunogenicity and safety in UK laboratory workers of a licensed Hib and meningococcal C conjugate combined vaccine (Menitorix)

Trial Profile

A phase IV, single group study to evaluate the immunogenicity and safety in UK laboratory workers of a licensed Hib and meningococcal C conjugate combined vaccine (Menitorix)

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Hib-meningococcal vaccine group C conjugate (Primary)
  • Indications Haemophilus infections; Meningococcal group C infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Sep 2007 Status change from in progress to completed
    • 16 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top